Grifols (GRFS) Dividends Paid - Common Growth (1y) (2011 - 2020)
Grifols (GRFS) Dividends Paid - Common Growth (1y) (2011 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 3.13% |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 5.50% |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 3.23% |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 15.53% |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | -1.92% |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 6.41% |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 3.41% |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 0.25% |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Grifols | 5.45 Bn | 4.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 7.39% |
| Dec 31, 2019 | 31.99% |
| Mar 31, 2019 | -36.97% |
| Dec 31, 2018 | -30.78% |
| Jun 30, 2018 | -67.14% |
| Mar 31, 2018 | 32.39% |
| Dec 31, 2017 | 187.30% |
| Dec 31, 2016 | 154.79% |
| Dec 31, 2015 | 250.06% |
| Jun 30, 2015 | 18.14% |
| Mar 31, 2015 | -3.92% |
| Dec 31, 2014 | -6,419,176.35% |
| Sep 30, 2014 | 7,011,093.98% |
| Jun 30, 2014 | -114.73% |
| Mar 31, 2014 | 75.44% |
| Jun 30, 2013 | -206,213.58% |
| Mar 31, 2013 | 247,086.60% |
| Jun 30, 2012 | -100.04% |
| Mar 31, 2012 | -99.91% |
| Sep 30, 2011 | -382.42% |